Calamos Advisors
WGS icon

Calamos Advisors’s GeneDx Holdings WGS Stock Holding History

Calamos Advisors’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,281
Closed -$468K – 1298
2026
Q1 		$468K Sell
7,281
-39,605
-84% -$3.61M ﹤0.01% 910
2025
Q4 		$6.1M Sell
46,886
-44
-0.1% -$6.04K 0.02% 500
2025
Q3 		$5.06M Buy
46,930
+2,355
+5% +$257K 0.02% 539
2025
Q2 		$4.11M Sell
44,575
-12,767
-22% -$1M 0.02% 574
2025
Q1 		$5.08M Sell
57,342
-2,185
-4% -$190K 0.02% 520
2024
Q4 		$4.58M Sell
59,527
-25,475
-30% -$1.78M 0.02% 529
2024
Q3 		$3.61M Buy
85,002
+41,514
+95% +$1.4M 0.02% 560
2024
Q2 		$1.14M Buy
+43,488
New +$824K 0.01% 635

Other funds holding WGS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Calamos Advisors's WGS Position: Q2 2026 in Review

Calamos Advisors sold out of GeneDx Holdings (WGS) in Q2 2026, closing a stake of 7,281 shares — an estimated $468K sold.

Calamos Advisors first reported a position in WGS in Q2 2024 and held it in 8 quarters. The position peaked at $6.1M in Q4 2025. 77 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Calamos Advisors reported no remaining GeneDx Holdings position as of Q2 2026 after selling out during the quarter.
  • Calamos Advisors sold 7,281 GeneDx Holdings shares in Q2 2026, an estimated $468K.
  • Calamos Advisors first reported a position in GeneDx Holdings in Q2 2024 and held it in 8 quarters.
  • Calamos Advisors's GeneDx Holdings position peaked at $6.1M in Q4 2025.
  • 77 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.